Alterations of p16INK4a and p14ARF in patients with severe oral epithelial dysplasia

Cancer Research

Volumn 62, Issue 18, 2002, Pages 5295-5300

  Kresty, Laura A ^a   Mallery, Susan R ^b   Knobloch, Thomas J ^a   Song, Huijuan ^a   Lloyd, Mary ^b   Casto, Bruce C ^a   Weghorst, Christopher M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PARAFFIN; PROTEIN P14; PROTEIN P16;

ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; CANCER STAGING; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA DETERMINATION; DYSPLASIA; EPITHELIUM CELL; EXON; FEMALE; GENE DELETION; GENE LOCUS; GENE MUTATION; GENETIC DAMAGE; GENETIC MARKER; HEAD AND NECK CANCER; HETEROZYGOSITY LOSS; HUMAN; MALE; MALIGNANT TRANSFORMATION; MICROSCOPIC ANATOMY; MOLECULAR DYNAMICS; MOUTH CANCER; MOUTH MUCOSA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN METHYLATION; PROTEIN STRUCTURE; REGULATOR GENE; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ALLELIC IMBALANCE; BIOPSY; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; FEMALE; GENE DELETION; GENE SILENCING; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0037105785     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
2. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma
3. Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancer
4. p16 mutation frequency and clinical correlation in head and neck cancer
5. p16 (MTS-1/CDKN2/INK4a) in cancer progression
6. The INK4A/ARF locus and its two gene products
7. The INK4a/ARF tumor suppressor: One gene-two products-two pathways
8. INK4a/CDKN2A tumor suppressor and its relatives
9. ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2
10. ARF links the turnout suppressors RB and p53
11. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients
12. 9p21 deletion correlates with recurrence in head and neck cancer
13. INK4a in oral premalignant lesions
14. Frequent microsatellite alterations at chromosome 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment
15. Patterns of CDKN2A gene loss in sequential oral epithelial dysplasias and carcinomas
16. Somatic INK4a-ARF locus mutations: A significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck
17. Predicting lung cancer by detecting aberrant promoter methylation in sputum
18. Semiautomated assessment of loss of heterozygosity and replication error in tumors
19. Head and neck cancer
20. Oral cavity and pharynx cancer incidence rates in the United States 1975-1998
21. Oral epithelial dysplasia and the development of invasive squamous carcinoma
22. Persistence of genetically altered fields in head and neck cancer patients: Biological and clinical implications
23. Allelotype of head and neck squamous cell carcinoma
24. Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: Role in response to chemoprevention and cancer development
25. High prevalence of p16 genetic alterations in head and neck tumours
26. Genetic progression model for head and neck cancer: Implications for field cancerization
27. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia
28. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy
29. A study of the etiological factors in cancer of the mouth
30. Head and neck cancer in nonsmokers: A distinct clinical and molecular entity
31. Carcinogenic effect of tobacco smoking and alcohol drinking on anatomic sites of the oral cavity and oropharynx
32. Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers
33. Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma
34. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers
35. The correlation between alteration of p16 gene and clinical status in oral squamous cell carcinoma
36. DNA studies underestimate the major role of CDKN2A inactivation in oral and oropharyngeal squamous cell carcinomas